FDA Inspection 886759 — Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
The FDA completed an inspection of Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. on Jun 12, 2014 in Changzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 12, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changzhou (China)